Paraneoplastic cerebellar ataxia and antibodies to metabotropic glutamate receptor 2.
Raquel Ruiz GarcíaEugenia Martínez-HernándezBastien JoubertMar Petit-PedrolElena Pajarón-BoixVerónica FernándezLidia SalaisMaría Del PozoThais ArmanguéLidia SabaterJosep DalmauFrancesc GrausPublished in: Neurology(R) neuroimmunology & neuroinflammation (2019)
mGluR2-Abs are a novel biomarker of paraneoplastic cerebellar ataxia. The potential pathogenic effect of the antibodies is not mediated by downregulation or internalization of neuronal surface mGluR2.